Literature DB >> 8381638

Virucidal effects of glucose oxidase and peroxidase or their protein conjugates on human immunodeficiency virus type 1.

Y Yamaguchi1, M Semmel, L Stanislawski, A D Strosberg, M Stanislawski.   

Abstract

Glucose oxidase and peroxidase (lactoperoxidase or myeloperoxidase) are virucidal to human immunodeficiency virus type 1 (HIV-1) in the presence of sodium iodide, as assessed by the loss of viral replication in a syncytium-forming assay or by the inhibition of cytopathic effects on infected cells. In the presence of low concentrations of sodium iodide, five HIV-1 isolates were equally susceptible to this virucidal system at enzyme concentrations of a few milliunits. The loss of viral replication was linearly related to the time of incubation in the enzyme solutions, with an inactivation rate of 1 log unit every 30 min. These enzymes and this halide were also cytotoxic to chronically infected, but not to uninfected, cultured CEM cells. Protein conjugates were prepared by using the enzymes and murine antibody 105.34, which recognized the V3 loop of HIV-1 LAI isolate surface glycoprotein, or recombinant human CD4. The protein conjugates inactivated free virus at rates similar to those of the free enzymes and were more effective than antibody or recombinant CD4 alone. These in vitro findings demonstrate that the peroxidase-H2O2-halide system provides potent virucidal activity against HIV-1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381638      PMCID: PMC187599          DOI: 10.1128/AAC.37.1.26

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  T cell depletion of human bone marrow using an oxidase-peroxidase enzyme immunotoxin.

Authors:  H Ito; J Morizet; L Coulombel; M Stanislawski
Journal:  Bone Marrow Transplant       Date:  1990-12       Impact factor: 5.483

2.  LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur.

Authors:  S Wain-Hobson; J P Vartanian; M Henry; N Chenciner; R Cheynier; S Delassus; L P Martins; M Sala; M T Nugeyre; D Guétard
Journal:  Science       Date:  1991-05-17       Impact factor: 47.728

3.  Targeted killing of yeast expressing a HIV-1 peptide by antibody-conjugated glucose oxidase and horseradish peroxidase.

Authors:  L Chouchane; T Bringman; S Barbier; F Traincard; A D Strosberg
Journal:  Immunol Lett       Date:  1990-09       Impact factor: 3.685

4.  Saliva can contribute in quick inhibition of HIV infectivity.

Authors:  M Pourtois; C Binet; N Van Tieghem; P R Courtois; A Vandenabbeele; L Thirty
Journal:  AIDS       Date:  1991-05       Impact factor: 4.177

5.  Activation of a beta-galactosidase recombinant provirus: application to titration of human immunodeficiency virus (HIV) and HIV-infected cells.

Authors:  D Rocancourt; C Bonnerot; H Jouin; M Emerman; J F Nicolas
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses.

Authors:  M Roederer; F J Staal; H Osada; L A Herzenberg; L A Herzenberg
Journal:  Int Immunol       Date:  1991-09       Impact factor: 4.823

7.  Studies on the lactoperoxidase system: reaction kinetics and antibacterial activity using two methods for hydrogen peroxide generation.

Authors:  D A Dionysius; P A Grieve; A C Vos
Journal:  J Appl Bacteriol       Date:  1992-02

8.  Immunoconjugates that neutralize HIV virions kill T cells infected with diverse strains of HIV-1.

Authors:  Y W Kim; M S Fung; N C Sun; C R Sun; N T Chang; T W Chang
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

9.  Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of the myeloperoxidase system.

Authors:  S J Klebanoff; R W Coombs
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

10.  Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies.

Authors:  J M Zarling; P A Moran; O Haffar; J Sias; D D Richman; C A Spina; D E Myers; V Kuebelbeck; J A Ledbetter; F M Uckun
Journal:  Nature       Date:  1990-09-06       Impact factor: 49.962

View more
  8 in total

1.  Expression and Characterization of Glucose Oxidase from Aspergillus niger in Yarrowia lipolytica.

Authors:  Fatemeh Khadivi Derakshan; Farshad Darvishi; Mehrouz Dezfulian; Catherine Madzak
Journal:  Mol Biotechnol       Date:  2017-08       Impact factor: 2.695

2.  Molecular heterogeneity and alternative splicing of human lactoperoxidase.

Authors:  Miryam A Fragoso; Aliza Torbati; Nevis Fregien; Gregory E Conner
Journal:  Arch Biochem Biophys       Date:  2008-11-24       Impact factor: 4.013

Review 3.  The mouth: a gateway or a trap for HIV?

Authors:  Daniel Malamud; Sharon M Wahl
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

4.  Inactivation of human immunodeficiency virus type 1 by the amine oxidase-peroxidase system.

Authors:  S J Klebanoff; F Kazazi
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

5.  Virucidal effect of myeloperoxidase on human immunodeficiency virus type 1-infected T cells.

Authors:  J Chochola; Y Yamaguchi; N Moguilevsky; A Bollen; A D Strosberg; M Stanislawski
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

Review 6.  Antimicrobial proteins and polypeptides in pulmonary innate defence.

Authors:  Mark P Rogan; Patrick Geraghty; Catherine M Greene; Shane J O'Neill; Clifford C Taggart; Noel G McElvaney
Journal:  Respir Res       Date:  2006-02-17

7.  Quantitative salivary proteomic differences in oral chronic graft-versus-host disease.

Authors:  Carol W Bassim; Kiran S Ambatipudi; Jacqueline W Mays; Dean A Edwards; Stephan Swatkoski; Helen Fassil; Kristin Baird; Marjan Gucek; James E Melvin; Steven Z Pavletic
Journal:  J Clin Immunol       Date:  2012-07-18       Impact factor: 8.317

Review 8.  Why whey? Camel whey protein as a new dietary approach to the management of free radicals and for the treatment of different health disorders.

Authors:  Gamal Badr; Nancy K Ramadan; Leila H Sayed; Badr M Badr; Hossam M Omar; Zeliha Selamoglu
Journal:  Iran J Basic Med Sci       Date:  2017-04       Impact factor: 2.699

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.